Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ... The Lancet infectious diseases 13 (9), 785-796, 2013 | 1974 | 2013 |
Methicillin-resistant Staphylococcus aureus AS Lee, H De Lencastre, J Garau, J Kluytmans, S Malhotra-Kumar, ... Nature reviews Disease primers 4 (1), 1-23, 2018 | 1650 | 2018 |
Guidelines for the management of adult lower respiratory tract infections‐Full version M Woodhead, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, ... Clinical microbiology and infection 17, E1-E59, 2011 | 1609 | 2011 |
Mortality after hospitalization for COPD P Almagro, E Calbo, AO de Echaguïen, B Barreiro, S Quintana, ... Chest 121 (5), 1441-1448, 2002 | 860 | 2002 |
A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 698 | 2009 |
Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments J Liñares, A Sitges-Serra, J Garau, JL Perez, R Martin Journal of Clinical Microbiology 21 (3), 357-360, 1985 | 667 | 1985 |
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases E Calbo, V Romaní, M Xercavins, L Gómez, CG Vidal, S Quintana, J Vila, ... Journal of Antimicrobial Chemotherapy 57 (4), 780-783, 2006 | 502 | 2006 |
Diagnosis of stroke-associated pneumonia CJ Smith, AK Kishore, A Vail, A Chamorro, J Garau, SJ Hopkins, ... Stroke, 2015 | 461 | 2015 |
Emergence and Dissemination of Quinolone-ResistantEscherichia coli in the Community J Garau, M Xercavins, M Rodríguez-Carballeira, JR Gómez-Vera, I Coll, ... Antimicrobial agents and chemotherapy 43 (11), 2736-2741, 1999 | 439 | 1999 |
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance IM Gould, MZ David, S Esposito, J Garau, G Lina, T Mazzei, G Peters International journal of antimicrobial agents 39 (2), 96-104, 2012 | 430 | 2012 |
Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin-Resistant Streptococcus pneumoniae JR Lonks, J Garau, L Gomez, M Xercavins, AO de Echagüen, IF Gareen, ... Clinical Infectious Diseases 35 (5), 556-564, 2002 | 420 | 2002 |
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control Y Carmeli, M Akova, G Cornaglia, GL Daikos, J Garau, S Harbarth, ... Clinical Microbiology and Infection 16 (2), 102-111, 2010 | 367 | 2010 |
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence P Ball, F Baquero, O Cars, T File, J Garau, K Klugman, DE Low, ... Journal of antimicrobial chemotherapy 49 (1), 31-40, 2002 | 357 | 2002 |
Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower … M Woodhead, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, ... Clin Microbiol Infect 17 (Suppl 6), E1-E59, 2011 | 355 | 2011 |
Predictive Factors for Invasive Disease Due to Penicillin-Resistant Streptococcus pneumoniae: A Population-Based Study JM Nava, F Bella, J Garau, J Lite, MA Morera, C Martí, D Fontanals, B Font, ... Clinical infectious diseases 19 (5), 884-890, 1994 | 281 | 1994 |
Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease P Almagro, B Barreiro, A Ochoa de Echagüen, S Quintana, ... Respiration 73 (3), 311-317, 2006 | 277 | 2006 |
Hub colonization as the initial step in an outbreak of catheter‐related sepsis due to coagulase negative staphylococci during parenteral nutrition A Sitges‐Serra, P Puig, J Linares, JL Perez, N Farrero, E Jaurrieta, ... Journal of Parenteral and Enteral Nutrition 8 (6), 668-672, 1984 | 276 | 1984 |
Similarity between Human and Chicken Escherichia coli Isolates in Relation to Ciprofloxacin Resistance Status JR Johnson, MA Kuskowski, M Menard, A Gajewski, M Xercavins, J Garau The Journal of infectious diseases 194 (1), 71-78, 2006 | 258 | 2006 |
Other antimicrobials of interest in the era of extended‐spectrum β‐lactamases: Fosfomycin, nitrofurantoin and tigecycline J Garau Clinical microbiology and infection 14, 198-202, 2008 | 257 | 2008 |
Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis C Garcia Vidal, S Rodríguez Fernández, J Martínez Lacasa, M Salavert, ... Clinical infectious diseases 40 (5), 756-759, 2005 | 215 | 2005 |